[Federal Register Volume 61, Number 170 (Friday, August 30, 1996)]
[Notices]
[Page 45987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22152]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 21, 1996, and published in the Federal Register 
on May 30, 1996, (61 FR 27099), Roche Diagnostic Systems, Inc., 1080 
U.S. Highway 202, Somerville, New Jersey 08876, made application to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)...........  I                         
Tetrahydrocannabinols (7370)................  I                         
------------------------------------------------------------------------

    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Roche Diagnostic Systems, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. Therefore, pursuant to 21 U.S.C. Sec. 823 
and 28 CFR Secs. 0.100 and 0.104, the Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacturer of 
the basic classes of controlled substances listed above is granted.

    Dated: August 21, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-22152 Filed 8-29-96; 8:45 am]
BILLING CODE 4410-09-M